| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |